Vital funding established for Evonetix projects
Financing will allow company’s development of DNA synthesis chip technology to commercial scale
Read Moreby John Pinching | Feb 7, 2023 | News | 0
Financing will allow company’s development of DNA synthesis chip technology to commercial scale
Read Moreby John Pinching | Jan 11, 2023 | News | 0
Candidate will go through the development programme, which includes safety and tolerability studies
Read Moreby John Pinching | Oct 27, 2022 | News | 0
UK only places 11th in terms of total R&D investment as a percentage of GDP
Read Moreby John Pinching | Aug 3, 2022 | News | 0
The sites will maximise local and global benefits of NHS, research, industry and community partnerships
Read Moreby John Pinching | Jun 6, 2022 | News | 0
New facility opens on the Cambridge Research Park offering sterile finish
Read Moreby Anna Smith | Sep 5, 2019 | News | 0
The licensing agreement enables the company’s “freedom to operate globally in the diagnostic field of certain selected radionuclide-labelled PARPi”.
Read Moreby Selina McKee | Jan 12, 2018 | News | 0
The NHS has now chosen 138 clinical entrepreneurs to design and deliver new technological solutions and innovations in healthcare, including the appointment of five healthcare scientists working on addressing conditions such as sickle cell disease and allergic reactions.
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479